These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1563379)
1. Effect of cilofungin on phagocytosis and intracellular killing of Candida albicans by human neutrophils. Richardson MD; Scott G; Shankland GS Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):22-6. PubMed ID: 1563379 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of human neutrophil phagocytosis of Candida albicans by a beta-glucan synthase inhibitor, cilofungin. Richardson MD; Smyth LA; Shankland GS FEMS Microbiol Immunol; 1991 Oct; 3(5):299-303. PubMed ID: 1797051 [TBL] [Abstract][Full Text] [Related]
3. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils. Meshulam T; Levitz SM; Diamond RD; Sugar AM J Antimicrob Chemother; 1989 Nov; 24(5):741-5. PubMed ID: 2689424 [TBL] [Abstract][Full Text] [Related]
4. Intracellular killing of Candida albicans by human neutrophils is potentiated by exposure to combinations of amphotericin B and 5-fluorocytosine. Richardson MD; Paton M; Shankland GS Mycoses; 1991; 34(5-6):201-4. PubMed ID: 1795714 [TBL] [Abstract][Full Text] [Related]
5. The effect of cilofungin (LY 121019) in combination with amphotericin B or flucytosine against Candida species. Bulo AN; Bradley SF; Kauffman CA Mycoses; 1989 Mar; 32(3):151-7. PubMed ID: 2733727 [TBL] [Abstract][Full Text] [Related]
6. The effect of cilofungin (LY 121019) in combination with amphotericin B or flucytosine against Candida species. Bulo AN; Bradley SF; Kauffman CA Mycoses; 1989 Jan; 32(1):46-52. PubMed ID: 2747742 [TBL] [Abstract][Full Text] [Related]
7. In-vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B-deoxycholate on human polymorphonuclear leucocytes. Van der Auwera P; Meunier F J Antimicrob Chemother; 1989 Nov; 24(5):747-63. PubMed ID: 2557318 [TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B. Meunier F; Lambert C; Van der Auwera P J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicans. Shadomy S; Shadomy HJ Diagn Microbiol Infect Dis; 1991; 14(1):21-2. PubMed ID: 2013207 [TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species. Smith KR; Lank KM; Dismukes WE; Cobbs CG Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435 [TBL] [Abstract][Full Text] [Related]
11. Effect of amorolfine (Ro 14-4767/002) on in vitro phagocytosis and intracellular killing of Candida albicans by human neutrophils. Richardson MD; Shankland GS; Gray CA Mycoses; 1989 May; 32(5):245-9. PubMed ID: 2668755 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of phagocytosis and intracellular killing of Candida albicans by human neutrophils in the presence of a morpholine antifungal derivative, Ro 14-4767. Richardson MD; Gray CA Ann N Y Acad Sci; 1988; 544():403-5. PubMed ID: 3063177 [No Abstract] [Full Text] [Related]
13. Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents. Pfaller M; Gordee R; Gerarden T; Yu M; Wenzel R Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):564-7. PubMed ID: 2504601 [TBL] [Abstract][Full Text] [Related]
14. In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils. Johnson EM; Warnock DW; Richardson MD; Douglas CJ J Antimicrob Chemother; 1986 Jul; 18(1):83-91. PubMed ID: 3019981 [TBL] [Abstract][Full Text] [Related]
15. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans. Angiolella L; Simonetti N; Cassone A J Antimicrob Chemother; 1994 Jun; 33(6):1137-46. PubMed ID: 7928807 [TBL] [Abstract][Full Text] [Related]
16. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes. Mínguez Mínguez F; Lima JE; García MT; Prieto J Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368 [TBL] [Abstract][Full Text] [Related]
17. In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes. Pallister CJ; Johnson EM; Warnock DW; Elliot PJ; Reeves DF J Antimicrob Chemother; 1992 Sep; 30(3):313-20. PubMed ID: 1452496 [TBL] [Abstract][Full Text] [Related]
18. Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections. Rennie RP; Hellman L Mycoses; 1989 Mar; 32(3):145-50. PubMed ID: 2733726 [TBL] [Abstract][Full Text] [Related]
20. Effects of antifungal agents on the function of human neutrophils in vitro. Roilides E; Walsh TJ; Rubin M; Venzon D; Pizzo PA Antimicrob Agents Chemother; 1990 Feb; 34(2):196-201. PubMed ID: 2158275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]